A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythmatosus

Journal of Rheumatology

Volumn 25, Issue 4, 1998, Pages 681-688

  Yoshio, Taku ^a   Masuyama, Jun Ichi ^a   Minota, Seiji ^a   Kaneko, Naoko ^a   Iwamoto, Masahiro ^a   Okazaki, Hitoaki ^a   Mimori, Akio ^a   Takeda, Akira ^a   Kano, Shogo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antiribosomal P protein antibodies; Antiribosomal P0 protein antibodies; Central nervous system lupus; Liver disease; Sytemic lupus erythematosus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; PROTEIN ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; LIVER DISEASE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVER DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHOSPHOPROTEINS; RIBOSOMAL PROTEINS; TIME FACTORS;

EID: 0031923431     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bonfa E, Golombek SJ, Kaufman LD, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987;317:265-71.
2. Schneebaum AB, Singleton JD, West SG, et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991;90:54-62.
3. Nojima Y, Minota S, Yamada A, Takaku F, Aotsuka S, Yokohari R. Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1992;51:1053-5.
4. Press J, Palayew K, Laxer RM, et al. Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. Arthritis Rheum 1996;39:671-6.
5. Watanabe T, Sate T, Uchiumi T, Arakawa M. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of antiribosomal P antibody. Lupus 1996;5:178-83.
6. Van Dam A, Nossent H, de Jong J, et al. Diagnostic value of antibodies against ribosomal phosphoproteins: a cross sectional and longitudinal study. J Rheumatol 1991;18:1026-34.
7. Sato T, Uchiumi T, Ozawa T, et al. Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease. J Rheumatol 1991;18:1681-4.
8. Teh LS, Bedwell AE, Isenberg DA, et al. Antibodies to protein P in systemic lupus erythematosus. Ann Rheum Dis 1992;51:489-94.
9. Petri M. Anti-ribosomal P antibodies in SLE: a prospective cohort study [abstract]. Arthritis Rheum 1996;39 Suppl:S292.
10. Yoshio T, Masuyama J-I, Ikeda M, et al. Quantification of antiribosomal PO protein antibodies by ELISA with recombinant PO fusion protein and their association with central nervous system disease in systemic lupus erythematosus. J Rheumatol 1995;22:1681-7.
11. Koren E, Reichlin MW, Koscec M, Fugate RD, Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992;89:1236-41.
12. Koren E, Schnitz W, Reichlin M. Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus. Arthritis Rheum 1993;36:1325-8.
13. Hulsey M, Goldstein R, Scully L, Surbeck W, Reichlin M. Anti-ribosomal P antibodies in systemic lupus erythematosus: a case-control study correlating hepatic and renal disease. Clin Immunol Immunopathol 1995;74:252-6.
14. Arnett FC, Reichlin M. Lupus hepatitis: under-recognized disease feature associated with autoantibodies to ribosomal P. Am J Med 1995;99:465-72.
15. Fox RA, Reichlin MW, Reichlin M, Isenberg DA. Liver function test abnormalities in systemic lupus erythematosus [abstract]. Br J Rheumatol 1997;36 Suppl:10.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
18. Koren E, Reichlin MW, Koscec M, Fugate RD, Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992;89:1236-41.
19. Koren E, Koscec M, Reichlin MW, Fugate RD, Reichlin M. Possible role of autoantibodies to ribosomal P proteins in development of liver disease in patients with systemic lupus erythematosus [abstract]. Arthritis Rheum 1993;36 Suppl:S72.